Where does Jan Garfinkle work?

Jan Garfinkle is Founder & Managing Partner at Arboretum Ventures and Board director at Reprieve Cardiovascular and Board director at Francis Medical and Board director at Koya Medical.

What check size does Jan Garfinkle write?

Jan Garfinkle typically writes checks of $10M – $15M.

What boards does Jan Garfinkle sit on?

Jan Garfinkle holds tracked board seats at CardioMEMS, Francis Medical, Koya Medical, Nxthera Inc, Rarecyte, Reprieve Cardiovascular, Strata Oncology.

What companies has Jan Garfinkle invested in?

Investments tracked here include AtaCor Medical, Baronova, CardioMEMS, CardioMEMS, Esperion, Francis Medical, HandyLab, Koya Medical, Nxthera, Rarecyte, Reprieve Cardiovascular, Uptake Medical.

Where did Jan Garfinkle go to school?

Jan Garfinkle studied at The Wharton School (Master of Business Administration - MBA); University of California, Berkeley (BSE, Bioengineering).

Jan Garfinkle

Investor

Founder & Managing Partner at Arboretum Ventures · Board director at Reprieve Cardiovascular · Board director at Francis Medical · Board director at Koya Medical

Detroit Metropolitan Area

Writes $10M – $15M checks · typically $10M

Find your path to Jan

131 people in our graph share verified history with Jan — schools, employers, funds. One of them is your warm intro.

Tiffany SpencerunlockedJan: together at National Venture Capital Association (2016–2018)

×7Jan: together at National Venture Capital Association

×3Jan: together at Arboretum Ventures

Jan: together at Francis Medical

About

Jan Garfinkle built a top-tier healthcare fund from Ann Arbor, proving Midwest firms can generate strong returns; she paired medical-device and large-energy operating experience and testified before the U.S. Senate.

Contact· self-published, not guessed

j•••@arboretumvc.comreveal

Invests in

BiotechDigital HealthHealthtechImpact & Social GoodMedical Devices

Board director at Reprieve Cardiovascular

Intro paths

→

In turn, Jan can intro founders to Reprieve Cardiovascular's investors below.

Reprieve Cardiovascular's investors · 6

Arboretum VenturesAnn Arbor · $5M – $15M checks · since 2025 Deerfield Management CompanyNew York · since 2020 Genesis Venture CapitalGrand Cayman Lightstone VenturesPortola Valley · since 2025 Rex Health VenturesRaleigh · $250K – $500K checks Sante VenturesAustin · $2M – $6M checks

Board director at Francis Medical

Intro paths

→

In turn, Jan can intro founders to Francis Medical's investors below.

Francis Medical's investors · 2

Arboretum VenturesAnn Arbor · $5M – $15M checks · since 2018 Solas BioVenturesChattanooga · since 2021

Co-founders at Francis Medical

Michael HoeyFounder

Board director at Koya Medical

Intro paths

→

In turn, Jan can intro founders to Koya Medical's investors below.

Koya Medical's investors · 6

Aphelion Capitalsince 2020 Arboretum VenturesAnn Arbor · $5M – $15M checks · since 2020 Cadence Healthcare VenturesHayward · since 2022 OrbiMedNew York · $1M – $75M checks · since 2020 Scientific Health DevelopmentDallas · $2M checks · since 2020 Zühlke VenturesZurich · $165K – $275K checks · since 2020

Co-founders at Koya Medical

Anand DoraiswamyExecutive Officer, Director

Experience

Arboretum VenturesManaging Partner, Foundercurrent2002 — presentAnn Arbor, MI
AtaCor Medical, Inc.Board Member, Investorcurrent2024 — present
Reprieve CardiovascularBoard Member, Investorcurrent2023 — present
RareCyte, Inc.Board Member, Investorcurrent2021 — present
Francis MedicalBoard Member, Investorcurrent2018 — present
Koya Medical, Inc.Board Member, Investorcurrent2020 — present
Bank of Ann ArborBoard Membercurrent2011 — present
Strata OncologyBoard Member, Investor2016 — 2024
Trinity Health System - Michigan RegionBoard Member2017 — 2023
NeuMoDx Molecular, Inc.Board Member, Investor2012 — 2020
National Venture Capital AssociationBoard Chair (2019-2020), Board Member (2015-2020)2015 — 2020
NxTheraBoard Member, Investor2008 — 2018
nVision MedicalBoard Observer, Investor2016 — 2018
Esperion Therapeutics, Ann Arbor, MIBoard Observer, Investor2008 — 2013
HandyLab, Inc.Board Member, Investor2004 — 2009
Strategic Marketing ConsultantsPresident1995 — 2002Ann Arbor, MI
Devices for Vascular Intervention/GuidantDirector of Marketing and Clinical Research1990 — 1995San Francisco Bay Area
Advanced Cardiovascular Systems/GuidantProduct Manager/Sales Representative1984 — 1990San Francisco Bay Area
Procter & GambleManufacturing Manager/Process Engineer1979 — 1982Greater Monroe Area

Skills & more

Healthcare4Board LeadershipVenture FinancingEarly Stage CompaniesVenture Capital8Start-ups13Business Strategy10Business Development3Entrepreneurship4Mergers & Acquisitions3Cross-functional Team Leadership2Corporate Development2

+7 more

Due DiligenceFundraisingPrivate EquityCommercializationStrategyStrategic PlanningManagement

From Jan's professional profile.

Deals · 6

Reprieve CardiovascularBoard seat

via Arboretum Ventures · filed Jun 2025 · $35.9M raise

RarecyteBoard seat

via Arboretum Ventures · filed Sep 2021 · $24M raise

Koya MedicalBoard seat

via Arboretum Ventures · filed Dec 2020 · $11M raise

Francis MedicalBoard seat

via Arboretum Ventures · filed Nov 2018 · $18.1M raise

Strata OncologyBoard seat

via Arboretum Ventures · filed May 2018 · $25M raise

Nxthera IncBoard seat

via Arboretum Ventures · filed Feb 2015 · $8M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

CardioMEMS

Investor

AtaCor MedicalBaronovaCardioMEMSCardioMEMSEsperionHandyLabNxtheraUptake Medical

Sources: SEC Form D filings · curated public sources · the firm's website.

Colleagues at Arboretum Ventures

Amanda Elder

Vice President of Finance at Arboretum Ventures

Amanda Goldstein

Senior Executive Assistant at Arboretum Ventures

Andrew Cleeland

Investor at Arboretum Ventures

Charity Tarn

Principal at Arboretum Ventures

Chris Eso

Investor at Arboretum Ventures

Cynthia Jones

Executive Assistant at Arboretum Ventures

Dan Kidle

Managing Partner at Arboretum Ventures

E. Selemon Asfaw

Investor at Arboretum Ventures

Frequently asked questions

Who is Jan Garfinkle?: Jan Garfinkle built a top-tier healthcare fund from Ann Arbor, proving Midwest firms can generate strong returns; she paired medical-device and large-energy operating experience and testified before the U.S. Senate.
Where does Jan Garfinkle work?: Jan Garfinkle is Founder & Managing Partner at Arboretum Ventures and Board director at Reprieve Cardiovascular and Board director at Francis Medical and Board director at Koya Medical.
What does Jan Garfinkle invest in?: Jan Garfinkle invests in Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
What check size does Jan Garfinkle write?: Jan Garfinkle typically writes checks of $10M – $15M.
What boards does Jan Garfinkle sit on?: Jan Garfinkle holds tracked board seats at CardioMEMS, Francis Medical, Koya Medical, Nxthera Inc, Rarecyte, Reprieve Cardiovascular, Strata Oncology.
What companies has Jan Garfinkle invested in?: Investments tracked here include AtaCor Medical, Baronova, CardioMEMS, CardioMEMS, Esperion, Francis Medical, HandyLab, Koya Medical, Nxthera, Rarecyte, Reprieve Cardiovascular, Uptake Medical.
Where did Jan Garfinkle go to school?: Jan Garfinkle studied at The Wharton School (Master of Business Administration - MBA); University of California, Berkeley (BSE, Bioengineering).